Inventor · disambiguated record
Eric Lorent
Also filed as: LORENT ERIC
7 granted patents·5 pending applications·20 citations·filing 2020–2023
79Inventor score
Files withABLYNX NV12
Top patents by PatentIndex Score
12 records- 0194US11208476B2Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 28, 2021·12 cites·12 claims
- 0292US11332525B2Polypeptides comprising immunoglobulin single variable domains targeting TNFA and IL-23ABLYNX NV·Filed 2021·Granted May 17, 2022·4 cites·14 claims
- 0389US11897951B2Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-αABLYNX NV·Filed 2021·Granted Feb 13, 2024·3 cites·18 claims
- 0488US11840566B2Methods of treating asthma with polypeptides targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 12, 2023·1 cites·18 claims
- 0574US12492248B2Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 9, 2025·0 cites·17 claims
- 0674US12384840B2Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Aug 12, 2025·0 cites·16 claims
- 0768US2024301049A1Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf alphaABLYNX NV·Filed 2023·Application pending·0 cites
- 0867US2021188965A1Polypeptides comprising immunoglobulin single variable domains targeting il-13 and tslpABLYNX NV·Filed 2020·Application pending·0 cites
- 0963US2021188963A1Polypeptides comprising immunoglobulin single variable domains targeting tnfa and il-23ABLYNX NV·Filed 2020·Application pending·0 cites
- 1056US12509522B2Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40LABLYNX NV·Filed 2021·Granted Dec 30, 2025·0 cites·20 claims
- 1155US2024117038A1Cx3cr1-binding compounds, methods and uses thereofABLYNX NV·Filed 2023·Application pending·0 cites
- 1250US2021188986A1Polypeptides comprising immunoglobulin single variable domains targeting tnfa and ox40lABLYNX NV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Lorent files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →